. 2019 May 19;25:3700–3715. doi: 10.12659/MSM.914162

Table 4.

Relationship between the expression of FTH1 and clinicopathological parameters in KIRC.

Clinicopathological parameters		n	Relevant expression of FTH1 (log₂X)
Clinicopathological parameters		n	Mean ±SD	t	p Value
Age (years)	<60	245	15.2660±0.51809	−1.534^a	0.126
Age (years)	≥60	288	15.3392±0.57304	−1.534^a	0.126
Gender	Male	345	15.2739±0.56296	−1.804^a	0.072
Gender	Female	188	15.3635±0.51938	−1.804^a	0.072
Lymph node metastasis	Yes	134	15.4146±0.61153	2.443^a	0.015^*
Lymph node metastasis	No	392	15.2159±0.78573	2.443^a	0.015^*
Stage	I–II	324	15.2195±0.53435	−4.580^a	0.000^*
Stage	III–IV	207	15.4396±0.54855	−4.580^a	0.000^*
T	T1–T2	342	15.2319±0.53832	−4.209^a	0.000^*
T	T3–T4	191	15.4375±0.54507	−4.209^a	0.000^*
Pathologic stage	I	267	15.2250±0.52511	F=8.503^b	0.000^*
	II	57	15.1938±0.57990
	III	123	15.3756±0.53859
	IV	84	15.5332±0.55273
Pathologic T	T1	273	15.2271±0.52558	F=6.478^b	0.000^*
	T2	69	15.2506±0.58975
	T3	180	15.4251±0.53334
	T4	11	15.6394±1.71110
M	No	422	15.2636±0.53297	−3.429^a	0.001^*
M	Yes	109	15.4641±0.58600	−3.429^a	0.001^*

SD – standard deviation; RCC – renal cell carcinoma.

A Student’s paired or unpaired t test was used for comparison between two group;

One-way analysis of variance (ANOVA) was performed.

p<0.05 was considered statistically significant.